Effect of Denosumab on Glucose Homeostasis in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors: A Pilot Study

BACKGROUND: Aromatase inhibitors in women with breast cancer have been associated with cancer treatment-induced bone loss (CTIBL), increased fracture risk, and impairment of glucose metabolism. Denosumab (Dmab), a monoclonal antibody against RANKL, which is a key regulator of the osteoclast activity...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossini, Alessandro, Frigerio, Sofia, Dozio, Elena, Trevisan, Roberto, Perseghin, Gianluca, Corbetta, Sabrina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666635/
https://www.ncbi.nlm.nih.gov/pubmed/33204260
http://dx.doi.org/10.1155/2020/1809150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666635/
https://www.ncbi.nlm.nih.gov/pubmed/33204260
http://dx.doi.org/10.1155/2020/1809150

Ejemplares similares